Welcome to our dedicated page for iTonic Holdings SEC filings (Ticker: ITOC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on iTonic Holdings's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into iTonic Holdings's regulatory disclosures and financial reporting.
iTonic Holdings Ltd director Zhang Pengfei filed an initial Form 3, which is a required statement of beneficial ownership for company insiders. This filing does not report any stock purchases, sales, option exercises, or other transactions; it simply establishes Zhang’s status as a reporting director at iTonic Holdings.
iTonic Holdings Ltd executive Li Zhixin, the company’s CFO, has filed an initial Form 3 as an officer of the company. The provided data does not show any insider transactions or derivative positions, indicating this filing functions mainly as a baseline ownership disclosure.
iTonic Holdings Ltd has filed a shelf registration to offer up to US$200,000,000 of Class A ordinary shares, preferred shares, debt securities, warrants, rights, depositary shares and units from time to time. The company’s Class A shares trade on Nasdaq under “ITOC,” with a public float of about US$4.0 million based on 9,382,000 Class A shares held by non‑affiliates as of February 3, 2026.
iTonic is a Cayman holding company whose healthcare and home‑care technology operations are conducted through subsidiaries in China and the U.S. Recent results show modest revenues and increasing net losses. The filing highlights significant legal and regulatory risks tied to operating in China, potential impacts from evolving PRC oversight of overseas offerings, and uncertainties related to PCAOB inspection requirements under the HFCA and Accelerating HFCA Acts, any of which could adversely affect the business and the value of its securities.
iTonic Holdings Ltd reported a board change and disclosed the standard terms of its director agreement. On January 22, 2026, independent director Yun Fai Wong resigned from the board for personal reasons, with the company stating there was no disagreement regarding its operations, policies or practices. The board simultaneously appointed Bin Wu as a new independent director and as a member of the Audit, Corporate Governance and Nominating, and Compensation Committees, and named him chair of the Corporate Governance and Nominating Committee.
iTonic notes that Bin Wu graduated from Wuhan University and holds an MBA from Duke University, and believes he meets Nasdaq and SEC independence standards. The filing includes a form of director agreement and indemnification agreement, outlining a fixed board term, quarterly cash fees, annual option grants under a share incentive plan, confidentiality and non-solicitation covenants, D&O insurance coverage, and Cayman Islands governing law.